Jonathan Freed, MD
Plastic and Reconstructive Surgery · Auburn, CANPI 1932200292
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.5%), gifts and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 95.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $6,628 and has fallen 63.1% since, to $2,446 in 2025. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 326 payments — averaging $60.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$19K
- Mentor Worldwide LLC$422
- Sientra, Inc.$245
- Galderma Laboratories, L.p.$71
- Motiva USA, LLC$68
- Musculoskeletal Transplant Foundation Inc.$47
Across 1 payment — averaging $1500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$2K
What the payments were for
- Speaking & faculty fees$9,74849%
- Food & beverage$3,74519%
- Education$510%
- Gifts$6,16231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 290 | $18,854 |
| Mentor Worldwide LLC | 18 | $422 |
| Sientra, Inc. | 9 | $245 |
| Galderma Laboratories, L.p. | 5 | $71 |
| Motiva USA, LLC | 2 | $68 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$6,162
How this compares
$19,706 in reported general payments places this provider in the 90th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $211 |
| Cephalexin | 26 | $154 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Auburn
- Mark SuskiThousand Oaks$294K
- Corey MaasSan Francisco$286K
- Arian MowlaviLaguna Beach$250K
- Charles LeeSan Francisco$200K
- David SieberSan Francisco$195K
- David KulberLos Angeles$194K
- Matthew NykielUpland$181K
- Subhas GuptaLoma Linda$178K
- Jeffrey HammoudehLos Angeles$159K
- Geoffrey GurtnerPalo Alto$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.